Kyle Kampman
Addiction Psychiatry Fellowship Director · University of Pennsylvania Health System
Credentials: · ·
History
PresentAddiction Psychiatry Fellowship · University of Pennsylvania Health System
- Present
Addiction Treatment and Medication Development Division and Medical Direct (ext. · University of Pennsylvania Health System
1994–1995- 1993–1994
University of Pennsylvania Treatment Research Center
- 1985–1986
Naval Hospital
- 1981–1985
- 1977–1981
Northwestern University
Research
Journal of Addiction Medicine · 2015 · First of 2 authors · 544 citations
Neuropsychopharmacology · 2007 · 274 citations
Archives of General Psychiatry · 2006 · 271 citations
60 papers
32 papers
28 papers
18 papers
- FL
17 papers · 4 as a resident
- JV
14 papers
12 papers
9 papers
Grants
- 2024–2027
National Institute on Drug Abuse · R61
PI · $967.1K · University of Pennsylvania
- 2023–2027
Rapid Outpatient Low-Dose Initiation of Buprenorphine for Individuals with OUD Using Fentanyl
National Institute on Drug Abuse · R34
Contact PI · $690K · University of Pennsylvania
- 2019–2026
The Whole Health Study: Collaborative Care for OUD and Mental Health Conditions
National Institute of Mental Health · UF1
PI · $13.3M · University of Pennsylvania
- 2019–2026
Combining Pregabalin with Lofexidine: Can It Increase the Success of Transition to Naltrexone?
National Institute on Drug Abuse · UH3
Contact PI · $8.2M · University of Pennsylvania
Clinical trials
- 2022–2023
- 2016–2018
Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study
Principal investigator · Completed · Phase 1
Temple University
- 2013–2017
Multicenter Trial of Combined Pharmacotherapy to Treat Cocaine Dependence
Principal investigator · Completed · Phase 2, Phase 3
New York State Psychiatric Institute
- 2012–2019
A Phase II Trial of Varenicline for the Treatment of Cocaine Dependence
Principal investigator · Completed · Phase 2
University of Pennsylvania